Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arcturus, CSL, Evolus, Galderma, Immunitybio, Nexus.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Hyloris, Otsuka, Theratechnologies.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allogene, Bayer, BMS, Corbus, Moderna, Oryzon, Pfizer.

Biopharmas raising money in public or private financings, including: Aptose, Inflarx, Matinas, Moleculin, Oculis, Sarepta.

New hires and promotions in the biopharma industry, including: Entero, Inhibikase, Loqus23, Nuclera, Nura, Olema, Zymeworks.

The top 10 biopharma stock gainers and losers for the week.

A quick look back at top stories.

Year-to-date money raised in public, private and other financings of biopharma companies.

Total raised in public, private and other financings of biopharma companies, comparing 2019-2024.

BioWorld's offices will be closed in observance of Presidents Day in the U.S. No issue will be published Monday, Feb. 17.